Verified earnings results
NeuroSense Therapeutics Q2 2026 Earnings Results
Direct answer
NeuroSense Therapeutics reported Q2 2026 results on September 25, 2026.
Revenue was 0. EPS beat the estimate by 35.66%.
The result is verified against Verified earnings source.
Verified earnings source
Get free NeuroSense Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- September 25, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -3.264
- Reported EPS
- -2.1
- Revenue
- 0
- EPS surprise
- EPS beat the estimate by 35.66%.
Explore related company data
Read the frequently asked questions.
When did NeuroSense Therapeutics report Q2 2026 earnings?
NeuroSense Therapeutics reported on September 25, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for NeuroSense Therapeutics?
The verified record provides an EPS estimate of -3.264.
Has NeuroSense Therapeutics reported the Q2 2026 result?
Revenue was 0. EPS beat the estimate by 35.66%.
Which source supports this NeuroSense Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.